Our leadership team integrates deep experience in scientific research, drug development, agriculture and capital markets. Our team has significant experience in growing both public and private companies and creating value through innovative intellectual property, novel consumer products and ground-breaking services in the life sciences industry. This unique combination of assets are fundamental to Emerald’s emergence as a leading international cannabis firm.
The Emerald Group of Companies are led by accomplished executives, from pharmaceutical R&D, plant genetics and large-scale agriculture to testing, product development, and marketing.
Our directors across the group of companies have deep experience in pharmaceutical business development, academic research, public policy, and life sciences investing.